• 咨询热线
    客服服务热线 13671568941/15317326293
  • 在线咨询
  • 微信客服
    微信客服
  • 公众号
    扫码关注公众号

CAY-10603

CAS No. 1045792-66-2

CAY-10603 ( CAY10603 )

产品货号. M10225 CAS No. 1045792-66-2

一种高效、选择性的 HDAC6 抑制剂,IC50 为 2 pM。

纯度: >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
规格 价格/人民币 库存 数量
2MG ¥497 有现货
5MG ¥843 有现货
10MG ¥1397 有现货
25MG ¥2688 有现货
50MG ¥3980 有现货
100MG ¥5373 有现货
500MG 获取报价 有现货
1G 获取报价 有现货
1 mL x 10 mM in DMSO ¥845 有现货

生物学信息

  • 产品名称
    CAY-10603
  • 注意事项
    本公司产品仅用于科研实验,不得用于人体或动物的临床与诊断
  • 产品简述
    一种高效、选择性的 HDAC6 抑制剂,IC50 为 2 pM。
  • 产品描述
    A highly potent and selective HDAC6 inhibitor with IC50 of 2 pM; 200-fold less potent for HDAC3 (IC50=0.42 nM) and no inhibition on HDAC1/2/8/10 (IC50> 100 nM); downregulates the levels of EGFR protein and synergizes with gefitinib to induce apoptosis of the lung adenocarcinoma cell lines.(In Vitro):CAY10603 (Compound 7) shows potent inhibitory activities against pancreatic cancer cell lines, with IC50s of 1, 0.3, 0.1, 0.1, 0.6, <1, 0.5 μM for BxPC-3, HupT3, Mia Paca-2, Panc 04.03, SU.86.86, HMEC, HPDE6c7, respectively. CAY10603 (100 nM, 200-300 nM) is active against both the Mia Paca-2 and Panc04.03 cell lines. CAY10603 inhibits HDAC6 deacetylase activity, and supresses the proliferation of lung adenocarcinoma cells. CAY10603 also induces apoptosis of lung adenocarcinoma cells. Furthermore, CAY10603 synergizes with gefitinib to induce apoptosis in lung adenocarcinoma cell lines, partly through the destabilization of EGFR and inactivation of the EGFR pathway.
  • 体外实验
    CAY10603 (Compound 7) shows potent inhibitory activities against pancreatic cancer cell lines, with IC50s of 1, 0.3, 0.1, 0.1, 0.6, <1, 0.5 μM for BxPC-3, HupT3, Mia Paca-2, Panc 04.03, SU.86.86, HMEC, HPDE6c7, respectively. CAY10603 (100 nM, 200-300 nM) is active against both the Mia Paca-2 and Panc04.03 cell lines. CAY10603 inhibits HDAC6 deacetylase activity, and supresses the proliferation of lung adenocarcinoma cells. CAY10603 also induces apoptosis of lung adenocarcinoma cells. Furthermore, CAY10603 synergizes with gefitinib to induce apoptosis in lung adenocarcinoma cell lines, partly through the destabilization of EGFR and inactivation of the EGFR pathway.
  • 体内实验
    ——
  • 同义词
    CAY10603
  • 通路
    Cell Cycle/DNA Damage
  • 靶点
    HDAC
  • 受体
    HDAC1|HDAC6
  • 研究领域
    Cancer
  • 适应症
    ——

化学信息

  • CAS Number
    1045792-66-2
  • 分子量
    446.4968
  • 分子式
    C22H30N4O6
  • 纯度
    >98% (HPLC)
  • 溶解度
    10 mM in DMSO
  • SMILES
    O=C(OC(C)(C)C)NC1=CC=C(C2=CC(C(NCCCCCCC(NO)=O)=O)=NO2)C=C1
  • 化学全称
    Carbamic acid, N-[4-[3-[[[7-(hydroxyamino)-7-oxoheptyl]amino]carbonyl]-5-isoxazolyl]phenyl]-, 1,1-dimethylethyl ester

运输与储存

  • 储存条件
    (-20℃)
  • 运输条件
    With Ice Pack
  • 稳定性
    ≥ 2 years

参考文献

1. Kozikowski AP, et al. J Med Chem. 2008 Aug 14;51(15):4370-3. 2. Wang Z, et al. Oncol Rep. 2016 Jul;36(1):589-97.
产品手册
关联产品
  • JAK/HDAC-IN-1

    JAK/HDAC-IN-1 是一种有效的 JAK2/HDAC 双重抑制剂(IC50:JAK2 和 HDAC 分别为 4 和 2 nM)。它还在几种血液细胞系中显示出抗增殖和促凋亡活性。

  • BRD4354

    BRD4354 是一种中等效力、选择性、可逆的 HDAC5 和 HDAC9 抑制剂,IC50 分别为 0.85 uM 和 1.88 uM。

  • ACY-1083

    ACY-1083 是一种选择性、脑穿透性 HDAC6 抑制剂 (IC50: 3 nM)。它对 HDAC6 的选择性比所有其他类别的 HDAC 亚型高 260 倍。